Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Eisai Co.
AddedFeb 15, 2024
UpdatedJun 28, 2026
Eisai Co.

Eisai Co.

Public

Eisai Co., Ltd., a Japanese pharmaceutical firm, produces and markets prescription drugs, medical equipment, and agrochemicals globally.

HQ
Tokyo, Tokyo, JP
Founded
1941
Overview
Compare
Employees

Eisai Co., Ltd. is a Japanese pharmaceutical company focused on producing and marketing prescription drugs, medical equipment, and agrochemicals globally. The company also manufactures diagnostic drugs and sells its products through subsidiaries and related companies in the US, Europe, and Asia.

Eisai has made significant strides in the pharmaceutical industry, contributing to advancements in healthcare through its innovative products. The company's global reach and diverse product offerings have established it as a key player in the market, impacting patient care worldwide.

Eisai Co. - Similar Companies

Taisho Pharmaceutical Holdings Co. logo

Taisho Pharmaceutical Holdings Co.

Astellas Pharma logo

Astellas Pharma

Otsuka Holdings Co. logo

Otsuka Holdings Co.

otsuka.com

Ajinomoto logo

Ajinomoto

AstraZeneca logo

AstraZeneca

astrazeneca.com

Fuji Pharma Co. logo

Fuji Pharma Co.

Taiho Pharmaceutical Co. logo

Taiho Pharmaceutical Co.

taiho.co.jp

Shionogi & Co. logo

Shionogi & Co.

Boehringer Ingelheim logo

Boehringer Ingelheim

Daiichi Sankyo logo

Daiichi Sankyo

daiichisankyo.com

Sumitomo Pharma Co. logo

Sumitomo Pharma Co.

Kyowa Kirin Co. logo

Kyowa Kirin Co.

kyowakirin.com

Japan Lifeline Co. logo

Japan Lifeline Co.

Merck & CO INC Cedear EAC 5 RE logo

Merck & CO INC Cedear EAC 5 RE

merck.com

ONO Pharmaceutical logo

ONO Pharmaceutical

Eisai Co. - Quick Facts

Who are Eisai Co.'s competitors?

Companies similar to Eisai Co. include Taisho Pharmaceutical Holdings Co., Astellas Pharma, Otsuka Holdings Co. and Ajinomoto.

When was Eisai Co. founded?

Eisai Co. was founded in 1941.

Where is Eisai Co.'s headquarters located?

Eisai Co.'s headquarters is located in Tokyo, Tokyo, JP.

How many employees does Eisai Co. have?

Eisai Co. has 11,076 employees as of Feb 6, 2024.

Eisai Co. - Classification

Industry
  • Hardware
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
  • Enterprise
Main Product
  • Medical Equipment
  • Pharmaceuticals
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research